JP2005535670A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005535670A5 JP2005535670A5 JP2004520655A JP2004520655A JP2005535670A5 JP 2005535670 A5 JP2005535670 A5 JP 2005535670A5 JP 2004520655 A JP2004520655 A JP 2004520655A JP 2004520655 A JP2004520655 A JP 2004520655A JP 2005535670 A5 JP2005535670 A5 JP 2005535670A5
- Authority
- JP
- Japan
- Prior art keywords
- function
- pharmacologically active
- platelet aggregation
- modified amino
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013543 active substance Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39689802P | 2002-07-17 | 2002-07-17 | |
| PCT/EP2003/007739 WO2004006907A1 (en) | 2002-07-17 | 2003-07-16 | Modified amino acid for the inhibition of platelet aggregation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005535670A JP2005535670A (ja) | 2005-11-24 |
| JP2005535670A5 true JP2005535670A5 (enExample) | 2006-08-24 |
| JP4541884B2 JP4541884B2 (ja) | 2010-09-08 |
Family
ID=30116066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004520655A Expired - Fee Related JP4541884B2 (ja) | 2002-07-17 | 2003-07-16 | 血小板凝集の阻害のための修飾アミノ酸 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20060106110A1 (enExample) |
| EP (1) | EP1556027B1 (enExample) |
| JP (1) | JP4541884B2 (enExample) |
| CN (1) | CN1668290B (enExample) |
| AT (1) | ATE538782T1 (enExample) |
| AU (1) | AU2003257473A1 (enExample) |
| BR (1) | BR0312712A (enExample) |
| CA (1) | CA2492378C (enExample) |
| ES (1) | ES2379949T3 (enExample) |
| PT (1) | PT1556027E (enExample) |
| TW (1) | TW200403052A (enExample) |
| WO (1) | WO2004006907A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007521232A (ja) | 2003-08-08 | 2007-08-02 | アブジェニックス・インコーポレーテッド | 副甲状腺ホルモン（ｐｔｈ）に対する抗体およびその使用 |
| US7318925B2 (en) | 2003-08-08 | 2008-01-15 | Amgen Fremont, Inc. | Methods of use for antibodies against parathyroid hormone |
| EP1907571B1 (en) | 2005-06-15 | 2017-04-26 | Complete Genomics Inc. | Nucleic acid analysis by random mixtures of non-overlapping fragments |
| CN101627011A (zh) * | 2005-09-19 | 2010-01-13 | 爱密斯菲尔科技公司 | N-(5-氯水杨酰基)-8-氨基辛酸的二钠盐的晶形 |
| US8895777B2 (en) | 2006-08-31 | 2014-11-25 | Emisphere Technologies Inc | Compounds and compositions for delivering active agents |
| PL2059260T3 (pl) * | 2006-08-31 | 2014-03-31 | Novartis Ag | Kompozycja farmaceutyczna obejmująca hGH do dostarczania doustnego |
| PL2215047T3 (pl) | 2007-11-02 | 2014-05-30 | Emisphere Tech Inc | Sposób leczenia niedoborów witaminy b12 |
| US20110207693A1 (en) * | 2010-02-24 | 2011-08-25 | Emisphere Technologies, Inc. | Oral B12 Therapy |
| RU2504536C1 (ru) * | 2012-08-20 | 2014-01-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Производное амида салициловой кислоты, обладающее антибактериальной, противогрибковой и антилизоцимной активностью |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260321A (en) * | 1984-11-12 | 1993-11-09 | Sandoz Ltd. | Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins |
| US5733647A (en) * | 1992-11-05 | 1998-03-31 | Polymer Innovations, Inc. | Insole |
| US5563158A (en) * | 1993-12-28 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
| US5866536A (en) * | 1995-03-31 | 1999-02-02 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| BR9604880A (pt) * | 1995-03-31 | 1998-05-19 | Emisphere Tech Inc | Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica |
| EP0993831B1 (en) * | 1997-02-07 | 2008-01-09 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US5773647A (en) * | 1997-02-07 | 1998-06-30 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| DE60017888T2 (de) * | 1999-04-05 | 2006-01-19 | Emisphere Technologies, Inc. | Dinatrium-salze, monohydrate und ethanol-solvate |
| US7049283B2 (en) * | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
-
2003
- 2003-07-15 TW TW092119264A patent/TW200403052A/zh unknown
- 2003-07-16 AU AU2003257473A patent/AU2003257473A1/en not_active Abandoned
- 2003-07-16 CA CA2492378A patent/CA2492378C/en not_active Expired - Fee Related
- 2003-07-16 ES ES03763878T patent/ES2379949T3/es not_active Expired - Lifetime
- 2003-07-16 EP EP03763878A patent/EP1556027B1/en not_active Expired - Lifetime
- 2003-07-16 PT PT03763878T patent/PT1556027E/pt unknown
- 2003-07-16 BR BR0312712-5A patent/BR0312712A/pt not_active IP Right Cessation
- 2003-07-16 CN CN038169231A patent/CN1668290B/zh not_active Expired - Fee Related
- 2003-07-16 JP JP2004520655A patent/JP4541884B2/ja not_active Expired - Fee Related
- 2003-07-16 US US10/521,492 patent/US20060106110A1/en not_active Abandoned
- 2003-07-16 WO PCT/EP2003/007739 patent/WO2004006907A1/en not_active Ceased
- 2003-07-16 AT AT03763878T patent/ATE538782T1/de active
-
2008
- 2008-07-08 US US12/169,184 patent/US20080280817A1/en not_active Abandoned
-
2011
- 2011-12-15 US US13/327,129 patent/US8664211B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004056337A3 (en) | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats | |
| NO2025027I1 (no) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget. | |
| JP2004210767A5 (enExample) | ||
| JP2005526147A5 (enExample) | ||
| JP2002532112A5 (enExample) | ||
| DE60143393D1 (de) | Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür | |
| NL300650I2 (nl) | Olodaterol, het R-enantiomeer daarvan, mengsels van isomeren daarvan, zuuradditiezouten met farmacologisch aanvaardbare zuren daarvan, evenals solvaten en/of hydraten daarvan, in het bijzonder Olodaterol en Olodaterolhydrochloride | |
| JP2004529078A5 (enExample) | ||
| JP2004532810A5 (enExample) | ||
| JP2004523498A5 (enExample) | ||
| BRPI9811803B8 (pt) | comprimido multiparticular aperfeiçoado de dissolução rápida | |
| JP2005525451A5 (enExample) | ||
| AU2002328343A1 (en) | Wax-based compositions and the use thereof as body care agents | |
| DE60117046D1 (de) | Kombination von fenofibrat und von coenzym q10 für die behandlung der endotheliaal missfunktion | |
| JP2005535670A5 (enExample) | ||
| JP2008519846A5 (enExample) | ||
| JP2003213455A5 (enExample) | ||
| JP2006508095A5 (enExample) | ||
| JP2000141643A5 (enExample) | ||
| WO2003008637A3 (en) | Use of genotyping in the individualization of therapy | |
| USD530485S1 (en) | Crotches for shorts | |
| JP2006199609A5 (enExample) | ||
| JP2009019158A5 (enExample) | ||
| JP2006527741A5 (enExample) | ||
| JP2005535635A5 (enExample) |